Data published by TIS Berlin: Trends in first trimester antiseizure medication use and treatment patterns

Researchers from the Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy (TIS Berlin) at the Institute of Clinical Pharmacology and Toxicology (Charité – Universitätsmedizin) have published data from the German Embryotox cohort (2000 to 2018) analysing trends in antiseizure medication (ASM) use at conception and changes in first trimester treatment pattern among those with epilepsy as reported to their TIS. More information is available here.

Photo by Milad Fakurian on Unsplash